TD Private Client Wealth LLC trimmed its holdings in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) by 4.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,101 shares of the business services provider’s stock after selling 672 shares during the period. TD Private Client Wealth LLC’s holdings in Exponent were worth $1,345,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of the business. Raymond James Financial Inc. acquired a new position in shares of Exponent in the 4th quarter valued at $55,131,000. JPMorgan Chase & Co. lifted its stake in shares of Exponent by 63.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock valued at $72,701,000 after purchasing an additional 245,086 shares during the period. Geode Capital Management LLC lifted its stake in shares of Exponent by 4.8% in the 3rd quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider’s stock valued at $173,597,000 after purchasing an additional 69,099 shares during the period. Barclays PLC lifted its stake in shares of Exponent by 219.0% in the 3rd quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock valued at $11,127,000 after purchasing an additional 66,263 shares during the period. Finally, TimesSquare Capital Management LLC lifted its stake in shares of Exponent by 22.4% in the 4th quarter. TimesSquare Capital Management LLC now owns 342,850 shares of the business services provider’s stock valued at $30,548,000 after purchasing an additional 62,760 shares during the period. 92.37% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, VP Richard Reiss sold 1,736 shares of the business’s stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the sale, the vice president now owns 1,800 shares of the company’s stock, valued at approximately $154,674. The trade was a 49.10 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.10% of the stock is owned by insiders.
Exponent Price Performance
Exponent (NASDAQ:EXPO – Get Free Report) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same period in the previous year, the company posted $0.41 earnings per share. Equities analysts expect that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Stories
- Five stocks we like better than Exponent
- How to Invest in Insurance Companies: A GuideĀ
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- What is the NASDAQ Stock Exchange?
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Stock Analyst Ratings and Canadian Analyst Ratings
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.